Free Trial

Securian Asset Management Inc. Trims Stock Position in The Procter & Gamble Company (NYSE:PG)

Procter & Gamble logo with Consumer Staples background
Remove Ads

Securian Asset Management Inc. decreased its holdings in The Procter & Gamble Company (NYSE:PG - Free Report) by 2.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 126,573 shares of the company's stock after selling 3,625 shares during the quarter. Procter & Gamble comprises 0.6% of Securian Asset Management Inc.'s investment portfolio, making the stock its 26th largest holding. Securian Asset Management Inc.'s holdings in Procter & Gamble were worth $21,220,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of PG. Raymond James Financial Inc. acquired a new stake in Procter & Gamble during the 4th quarter worth approximately $1,010,685,000. Geode Capital Management LLC lifted its stake in Procter & Gamble by 7.0% during the third quarter. Geode Capital Management LLC now owns 55,204,776 shares of the company's stock worth $9,538,327,000 after purchasing an additional 3,619,466 shares during the last quarter. Bank Julius Baer & Co. Ltd Zurich lifted its stake in Procter & Gamble by 1,195.1% during the fourth quarter. Bank Julius Baer & Co. Ltd Zurich now owns 3,222,585 shares of the company's stock worth $580,596,000 after purchasing an additional 2,973,757 shares during the last quarter. Franklin Resources Inc. lifted its stake in Procter & Gamble by 10.2% in the third quarter. Franklin Resources Inc. now owns 18,988,721 shares of the company's stock valued at $3,290,573,000 after buying an additional 1,760,214 shares during the last quarter. Finally, B. Metzler seel. Sohn & Co. Holding AG bought a new stake in Procter & Gamble in the third quarter valued at $301,950,000. 65.77% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several brokerages have recently issued reports on PG. Barclays lifted their price objective on shares of Procter & Gamble from $155.00 to $159.00 and gave the stock an "equal weight" rating in a research note on Thursday, January 23rd. JPMorgan Chase & Co. reduced their target price on shares of Procter & Gamble from $186.00 to $181.00 and set an "overweight" rating for the company in a research note on Thursday, January 16th. Royal Bank of Canada reiterated a "sector perform" rating and issued a $164.00 target price on shares of Procter & Gamble in a research note on Thursday, January 23rd. Piper Sandler reduced their price objective on shares of Procter & Gamble from $173.00 to $172.00 and set a "neutral" rating for the company in a research note on Monday, February 24th. Finally, Stifel Nicolaus increased their price target on shares of Procter & Gamble from $161.00 to $165.00 and gave the company a "hold" rating in a report on Thursday, January 23rd. Seven equities research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, Procter & Gamble presently has an average rating of "Moderate Buy" and a consensus price target of $181.47.

Remove Ads

View Our Latest Research Report on Procter & Gamble

Procter & Gamble Trading Down 1.8 %

NYSE:PG opened at $173.07 on Wednesday. The company has a quick ratio of 0.55, a current ratio of 0.76 and a debt-to-equity ratio of 0.50. The firm has a market capitalization of $405.83 billion, a P/E ratio of 27.56, a P/E/G ratio of 3.76 and a beta of 0.41. The company has a fifty day moving average of $167.14 and a 200 day moving average of $169.84. The Procter & Gamble Company has a 52 week low of $153.52 and a 52 week high of $180.43.

Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings results on Wednesday, January 22nd. The company reported $1.88 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.86 by $0.02. Procter & Gamble had a net margin of 18.35% and a return on equity of 33.00%. The company had revenue of $21.88 billion for the quarter, compared to analysts' expectations of $21.66 billion. During the same quarter in the previous year, the business posted $1.84 EPS. Procter & Gamble's revenue was up 2.1% compared to the same quarter last year. On average, research analysts predict that The Procter & Gamble Company will post 6.91 earnings per share for the current year.

Procter & Gamble Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, February 18th. Investors of record on Friday, January 24th were given a $1.0065 dividend. The ex-dividend date of this dividend was Friday, January 24th. This represents a $4.03 dividend on an annualized basis and a yield of 2.33%. Procter & Gamble's dividend payout ratio is presently 64.01%.

Insider Buying and Selling

In related news, insider Marc S. Pritchard sold 90,450 shares of the stock in a transaction dated Thursday, January 23rd. The stock was sold at an average price of $163.84, for a total transaction of $14,819,328.00. Following the transaction, the insider now owns 172,814 shares of the company's stock, valued at approximately $28,313,845.76. This represents a 34.36 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Gary A. Coombe sold 18,000 shares of the company's stock in a transaction that occurred on Tuesday, February 25th. The shares were sold at an average price of $171.66, for a total value of $3,089,880.00. Following the completion of the transaction, the chief executive officer now directly owns 22,051 shares of the company's stock, valued at $3,785,274.66. This trade represents a 44.94 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 143,450 shares of company stock worth $23,988,008 over the last three months. 0.18% of the stock is owned by insiders.

About Procter & Gamble

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Read More

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG - Free Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Procter & Gamble Right Now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

7 Stocks to Benefit From Trump’s Tariffs in 2025

7 Stocks to Benefit From Trump’s Tariffs in 2025

While the impact of these tariffs remains uncertain, some stocks are positioned to thrive under these policies; check out these 7 stock picks now.

Recent Videos

Best ETFs for Spring 2025: Strong and Steady Investing
Is There Still Money in AI? How to Invest in the Next Big Wave
AMD at Rock Bottom? Analysts Predict a MAJOR Rebound!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads